Supervisory Board of Schering AG appoints further member to Executive Board

07-Jul-2004

Schering AG announced that its Supervisory Board has appointed Dr. Karin Dorrepaal to the Board of Executive Directors of Schering AG. Dr. Dorrepaal (43) will be joining the company on September 1, 2004 and will be responsible for Schering's Global Business Unit Diagnostic Imaging as well as for its supply chain and Procurement.

"Dr. Dorrepaal's deep understanding of the pharmaceutical industry together with her experience in the strategic repositioning of top tier companies and in optimizing their performance will further strengthen Schering's management team," said Dr. Hubertus Erlen, Chairman of the Executive Board of Schering AG.

After four years as a research fellow at the Netherlands Cancer Institute, Dr. Dorrepaal received her Ph.D. in medicine from the Free University of Amsterdam, The Netherlands. She went on to study at the Rotterdam School of Management where she obtained an MBA. In 1990, Dr. Dorrepaal joined Booz Allen Hamilton, Management Consultants. She specialized in the pharmaceutical industry and advised major companies on issues regarding strategy, sales, marketing and supply chain. At the Schering Group, Dr. Dorrepaal took charge of several projects including re-designing sales and marketing functions in Europe, Asia, Latin America and Canada. In 2000, Dr. Dorrepaal was appointed Vice President of Booz Allen.

The appointment of a further member to Schering's Board of Executive Directors is related to the retirement of two of its current members, Prof. Dr. Günter Stock and Mr. Lutz Lingnau, at the end of 2005. It follows the appointment of Marc Rubin, M.D. to the Executive Board of Schering last year.

https://www.chemeurope.com/en/news/38374/supervisory-board-of-schering-ag-appoints-further-member-to-executive-board.html